The revenue stands at ₹8,828.30 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.99 per cent from ₹8,572.10 crore. This corresponds to a year-on-year *(YoY) growth of 9.83 per cent.
Operating Profit stands at ₹420.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.69 per cent from ₹373.50 crore. This corresponds to a year-on-year *(YoY) growth of 8.12 per cent.
PBDT stands at ₹912.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 6.03 per cent from ₹971.20 crore. This corresponds to a year-on-year *(YoY) decline of 6.16 per cent.
Profit Before Tax stands at ₹1,744.80 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.41 per cent from ₹1,905.00 crore. This corresponds to a year-on-year *(YoY) decline of 9.00 per cent.
Net Profit stands at ₹1,347.10 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 5.01 per cent from ₹1,418.10 crore. This represents a 7.28 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Reddy's Labs | -2.86% | -3.86% | -3.15% | -3.10% | -4.93% | -12.00% |
| Divi's Lab. | -0.82% | 3.22% | 4.83% | 7.57% | -5.66% | 13.28% |
| Torrent Pharma. | -1.50% | 3.74% | 7.10% | 13.55% | 20.14% | 21.28% |
| Cipla | -0.46% | -3.33% | -2.02% | -3.43% | -2.09% | -1.85% |
| Lupin | -1.09% | 3.97% | 6.69% | 11.85% | 14.44% | -2.77% |
| Mankind Pharma | -2.34% | 2.20% | 3.30% | -9.22% | -10.86% | -20.42% |
| Zydus Lifesci. | -2.04% | -0.79% | -1.15% | -8.71% | -7.05% | -9.92% |
Co-Chairman & Managing Director : G V Prasad
Executive Chairman : K Satish Reddy
Independent Director : Shikha Sanjaya Sharma
Independent Director : Leo Puri
Independent Director : K P Krishnan
Independent Director : Pennv Wan
Company Sec. & Compli. Officer : K Randhir Singh
Independent Director : Arun M. Kumar
Independent Director : Claudio Albrecht
Independent Director : Sanjiv Mehta
Independent Director : Alpna Seth